ADSL and tuberculosis: In the search for novel anti-TB therapeutics in combating MDR-TB, antimicrobial peptides (AMPs) are regarded as auspicious candidates due to their ability to inhibit the growth of Mtb with multiple mechanisms and immunomodulation activity [5, 6].